Faaliyet nakit akışı · 2025 mali yılı
| 1 | Johnson & JohnsonJNJ | $24,5B |
|---|---|---|
| 2 | UnitedHealth GroupUNH | $19,7B |
| 3 | AbbVieABBV | $19,0B |
| 4 | Novo Nordisk A SNVO | $18,0B |
| 5 | Eli LillyLLY | $16,8B |
| 6 | MerckMRK | $16,5B |
| 7 | AstraZenecaAZN | $14,6B |
| 8 | Bristol Myers SquibbBMY | $14,2B |
| 9 | HCA HealthcareHCA | $12,6B |
| 10 | PfizerPFE | $11,7B |